Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Frail elderly patients with relapsed-refractory multiple myeloma: efficacy and toxicity profile of the combination of bortezomib, high-dose dexamethasone, and low-dose oral cyclophosphamide.

× No keyword cloud information.

5 in total

Review 1. Evidence-based mini-review: treatment options for patients with relapsed/refractory myeloma previously treated with novel agents and high-dose chemotherapy and autologous stem-cell transplantation.

Authors: Nina Shah; Sagar Lonial
Journal: Hematology Am Soc Hematol Educ Program Date: 2010

2. Human MutT homologue 1 mRNA overexpression correlates to poor response of multiple myeloma.

Authors: Huixing Zhou; Yuan Jian; Yun Leng; Nian Liu; Ying Tian; Guorong Wang; Wen Gao; Guangzhong Yang; Wenming Chen
Journal: Int J Hematol Date: 2016-11-15 Impact factor: 2.490

3. Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE study.

Authors: Meletios A Dimopoulos; A Keith Stewart; Tamás Masszi; Ivan Špička; Albert Oriol; Roman Hájek; Laura Rosiñol; David Siegel; Georgi G Mihaylov; Vesselina Goranova-Marinova; Péter Rajnics; Aleksandr Suvorov; Ruben Niesvizky; Andrzej Jakubowiak; Jesus San-Miguel; Heinz Ludwig; Antonio Palumbo; Mihaela Obreja; Sanjay Aggarwal; Philippe Moreau
Journal: Br J Haematol Date: 2017-02-17 Impact factor: 6.998

4. Successful use of cyclophosphamide as an add-on therapy for multiple myeloma patients with acquired resistance to bortezomib or lenalidomide.

Authors: Shigeki Ito; Tatsuo Oyake; Kazunori Murai; Yoji Ishida
Journal: Case Rep Hematol Date: 2013-03-28

5. Efficacy of bortezomib as first-line treatment for patients with multiple myeloma.

Authors: Utkarsh Painuly; Shaji Kumar
Journal: Clin Med Insights Oncol Date: 2013-02-28

5 in total